Detailed price information for Kalvista Pharmaceuticals Inc (KALV-Q) from The Globe and Mail including charting and trades.

Review the current KalVista Pharmaceuticals Inc (KALV:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if KALV is the best investment for you.

Astria Therapeutics' Navenibart shows promise in phase 3 trials for hereditary angioedema. Click here to find out why ATXS ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Ekterly (sebetralstat) 0for the ...

Get the annual and quarterly balance sheet of KalVista Pharmaceuticals, Inc. (KALV) including details of assets, liabilities and shareholders' equity.

KALV SEC Filings Filing Type: Financials KalVista Pharmaceuticals, Inc. (KALV) - 10-K - Annual Report SEC FilingsThu, Jul. 10 ...

Find out all the key statistics for KalVista Pharmaceuticals, Inc. (KALV), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Find the latest KalVista Pharmaceuticals, Inc. (KALV) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find annual and quearterly earnings data for KalVista Pharmaceuticals, Inc. Common Stock (KALV) including earnings per share, earnings forecasts at Nasdaq.com.